These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28742376)

  • 1. Hypervascular Transformation of Hypovascular Hypointense Nodules in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI: A Systematic Review and Meta-Analysis.
    Suh CH; Kim KW; Pyo J; Lee J; Kim SY; Park SH
    AJR Am J Roentgenol; 2017 Oct; 209(4):781-789. PubMed ID: 28742376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Hypervascular Hypointense Nodules at Gadoxetic Acid MRI: Hepatocellular Carcinoma Risk Assessment with Emphasis on the Role of Diffusion-Weighted Imaging.
    Briani C; Di Pietropaolo M; Marignani M; Carbonetti F; Begini P; David V; Iannicelli E
    J Gastrointest Cancer; 2018 Sep; 49(3):302-310. PubMed ID: 28547117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypovascular hypointense nodules on hepatobiliary phase without T2 hyperintensity on gadoxetic acid-enhanced MR images in patients with chronic liver disease: long-term outcomes and risk factors for hypervascular transformation.
    Kim YS; Song JS; Lee HK; Han YM
    Eur Radiol; 2016 Oct; 26(10):3728-36. PubMed ID: 26670318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.
    Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T
    Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: risk of HCC recurrence after radiofrequency ablation.
    Lee DH; Lee JM; Lee JY; Kim SH; Kim JH; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK; Choi BI
    J Hepatol; 2015 May; 62(5):1122-30. PubMed ID: 25529623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-hypervascular Hypointense Nodules on Hepatocyte Phase Gadoxetic Acid-Enhanced MR Images: Transformation of MR Hepatobiliary Hypointense Nodules into Hypervascular Hepatocellular Carcinomas.
    Cho YK; Kim JW; Kim MY; Cho HJ
    Gut Liver; 2018 Jan; 12(1):79-85. PubMed ID: 28798287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
    Jang KM; Kim SH; Kim YK; Choi D
    Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrahepatic distant recurrence after radiofrequency ablation for hepatocellular carcinoma: precursor nodules on pre-procedural gadoxetic acid-enhanced liver magnetic resonance imaging.
    Song KD; Rhim H; Lee MW; Kim YS; Kang TW
    Acta Radiol; 2017 Jul; 58(7):778-785. PubMed ID: 27903759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypovascular hypointense nodules on hepatobiliary phase gadoxetic acid-enhanced MR images in patients with cirrhosis: potential of DW imaging in predicting progression to hypervascular HCC.
    Kim YK; Lee WJ; Park MJ; Kim SH; Rhim H; Choi D
    Radiology; 2012 Oct; 265(1):104-14. PubMed ID: 22891358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypervascular transformation of hepatobiliary phase hypointense nodules without arterial phase hyperenhancement on gadoxetic acid-enhanced MRI: long-term follow-up in a surveillance cohort.
    Park HJ; Lee TY; Kim SY; Kim MJ; Singal AG; Lee SJ; Won HJ; Byun JH; Lim YS
    Eur Radiol; 2022 Aug; 32(8):5064-5074. PubMed ID: 35229195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence for progression of hypervascular HCC in hypovascular hepatic nodules showing hyperintensity on gadoxetic acid-enhanced hepatobiliary phase in patients with chronic liver diseases.
    Matsuda M; Tsuda T; Yoshioka S; Murata S; Tanaka H; Hirooka M; Hiasa Y; Mochizuki T
    Jpn J Radiol; 2014 Jul; 32(7):405-13. PubMed ID: 24854900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
    Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O
    J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between non-hypervascular hypointense nodules on gadoxetic acid-enhanced MRI and liver stiffness or hepatocellular carcinoma.
    Hwang JA; Kang TW; Kim YK; Kim SH; Paik YH; Ha SY; Kim S
    Eur J Radiol; 2017 Oct; 95():362-369. PubMed ID: 28987693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
    Lee MH; Kim SH; Park MJ; Park CK; Rhim H
    AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of a hypovascular hepatic nodule showing hypointensity on hepatocyte-phase image is a risk factor for hypervascular hepatocellular carcinoma.
    Ichikawa S; Ichikawa T; Motosugi U; Sano K; Morisaka H; Enomoto N; Matsuda M; Fujii H; Araki T
    J Magn Reson Imaging; 2014 Feb; 39(2):293-7. PubMed ID: 23633285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of hypervascularization in small hypovascular hepatic nodules showing hypointense in the hepatobiliary phase of gadoxetic acid-enhanced MRI in patients with chronic liver disease.
    Takechi M; Tsuda T; Yoshioka S; Murata S; Tanaka H; Hirooka M; Mochizuki T
    Jpn J Radiol; 2012 Nov; 30(9):743-51. PubMed ID: 23001373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC.
    Toyoda H; Kumada T; Tada T; Sone Y; Maeda A; Kaneoka Y
    Hepatol Int; 2015 Jan; 9(1):84-92. PubMed ID: 25788383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of Hepatic Hypovascular Nodules with Hypointensity in the Hepatobiliary Phase of Gd-EOB-DTPA-enhanced MRI in Hepatocellular Carcinoma Cases.
    Saitoh T; Sato S; Yazaki T; Tobita H; Miyake T; Ishihara S; Katsube T; Kitagaki H; Kinoshita Y
    Intern Med; 2018 Jan; 57(2):165-171. PubMed ID: 29033416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonhypervascular Hypointense Nodules at Gadoxetic Acid-enhanced MR Imaging in Chronic Liver Disease: Diffusion-weighted Imaging for Characterization.
    Hwang J; Kim YK; Jeong WK; Choi D; Rhim H; Lee WJ
    Radiology; 2015 Jul; 276(1):137-46. PubMed ID: 25734551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatobiliary phase hypointense nodule without arterial phase hyperenhancement: are they at risk of HCC recurrence after ablation or surgery? A systematic review and meta-analysis.
    Kim TH; Woo S; Han S; Suh CH; Lee DH; Lee JM
    Eur Radiol; 2020 Mar; 30(3):1624-1633. PubMed ID: 31776747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.